GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
68.00
+1.76 (2.66%)
Apr 24, 2026, 2:13 PM EDT - Market open

GeneDx Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,9923,8042,153711031,082
Market Cap Growth
-17.45%76.64%2914.13%-30.33%-90.53%83.49%
Enterprise Value
1,8973,7372,12556.9244.87666.13
Last Close Price
68.00130.0676.862.758.71147.18
PE Ratio
--178.16-39.62-0.38-0.16-1.96
Forward PE
74.50-190.96---
PS Ratio
4.578.907.050.350.445.10
PB Ratio
6.2912.348.780.310.402.79
P/TBV Ratio
6.4612.098.430.290.351.24
P/FCF Ratio
137.12266.70-63.36-0.39-0.31-5.42
P/OCF Ratio
58.76114.30-75.57-0.40-0.32-5.68
EV/Sales Ratio
4.448.746.960.280.193.14
EV/EBITDA Ratio
149.98307.61-1686.51-0.39-0.07-1.57
EV/EBIT Ratio
--285.74-91.54-0.32-0.07-1.49
EV/FCF Ratio
133.05262.00-62.52-0.31-0.14-3.33
Debt / Equity Ratio
0.340.340.460.510.260.03
Debt / EBITDA Ratio
8.948.94-92.20-0.81-0.12-0.03
Debt / FCF Ratio
7.627.62-3.42-0.64-0.22-0.05
Net Debt / Equity Ratio
-0.20-0.20-0.10-0.05-0.20-1.07
Net Debt / EBITDA Ratio
-5.16-5.1619.860.070.090.98
Net Debt / FCF Ratio
-4.39-4.390.740.060.162.08
Asset Turnover
0.910.910.730.450.450.53
Inventory Turnover
10.5210.5211.4310.0311.107.83
Quick Ratio
2.262.263.262.771.164.22
Current Ratio
2.462.463.613.101.474.77
Return on Equity (ROE)
-7.60%-7.60%-22.10%-72.97%-171.07%-67.51%
Return on Assets (ROA)
-2.76%-2.76%-5.50%-39.50%-117.30%-110.74%
Return on Invested Capital (ROIC)
-4.80%-4.80%-9.25%-67.37%-355.97%-533.88%
Return on Capital Employed (ROCE)
-3.36%-3.36%-6.41%-51.12%-167.03%-141.41%
Earnings Yield
-1.07%-0.56%-2.52%-262.91%-615.73%-50.90%
FCF Yield
0.73%0.37%-1.58%-259.51%-318.22%-18.47%
Buyback Yield / Dilution
-6.51%-6.51%-10.61%-137.51%-212.56%-2106257.53%
Total Shareholder Return
-6.51%-6.51%-10.61%-137.51%-212.56%-2106257.53%
Updated Feb 23, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q